肝细胞癌的区域治疗方法:现状和未来前景
Jian-Jian Chen1, Zhi-Cheng Jin1, Bin-Yan Zhong2
1Department of Radiology, Center of Interventional Radiology & Vascular Surgery, Zhongda Hospital, Medical School, Southeast University, Nanjing, China.
United European gastroenterology journal
|February 19, 2024
概括
地方区域疗法 (LRT) 对于治疗肝细胞癌 (HCC) 是至关重要的. 将LRT与向药物或免疫疗法结合起来,有望改善HCC治疗患者的治疗结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是一种流行癌症,死亡率高.
- 地方区域疗法 (LRT) 是跨越不同阶段的HCC管理的组成部分.
- 对LRT的治疗选择涉及患者状态,瘤特征和技术因素.
研究的目的:
- 对肝细胞癌 (HCC) 的当前局部区域疗法 (LRT) 进行审查.
- 讨论将LRT与针对性药物和HCC的免疫疗法结合在一起的潜在好处.
- 探索HCC治疗策略的未来方向,整合LRT和新疗法.
主要方法:
- 对HCC中LRT现有研究的文献综述.
- 分析支持组合疗法的证据 (LRT + 向药物/免疫疗法).
- 与HCC治疗相关的当前临床和基础科学发现的综合.
主要成果:
- 慢性转录疗法是针对HCC的既定治疗方法,选择基于特定的患者和瘤因素.
- 将LRT与分子向剂结合起来已经证明了有效性.
- 新出现的证据表明,将LRT与免疫检查点抑制剂和向剂结合起来,有显著的治疗益处.
结论:
- 长途运输系统仍然是HCC管理的基石.
- 涉及LRT与向治疗和免疫治疗的组合策略代表了一个有希望的前沿.
- 对这些综合方法的进一步研究是有必要的,以优化HCC治疗结果.
更多相关视频
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
9.5K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K